Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,908
datasets available to search
ShareScore release 0.9.0
Dataset results
1,908 results for “dexamethasone”
Safety and Efficacy of Pomalidomide, Bortezomib and Low-dose Dexamethasone in Subjects With Relapsed or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT01734928. IPD Sharing: Not stated. Countries: 22. Publications: 2.
Lenalidomide and Dexamethasone With or Without Thalidomide in Treating Patients With Multiple Myeloma
ClinicalTrials.gov study NCT00098475. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Dexamethasone Solution and Dexamethasone in Mucolox™
ClinicalTrials.gov study NCT04540133. IPD Sharing: NO. Countries: 1. Publications: 1.
Phase 1b Multicenter Study of Carfilzomib With Lenalidomide and Dexamethasone in Relapsed Multiple Myeloma
ClinicalTrials.gov study NCT00603447. IPD Sharing: Not stated. Countries: 2. Publications: 2.
Lenalidomide and Dexamethasone With or Without Bortezomib in Treating Patients With Previously Untreated Multiple Myeloma
ClinicalTrials.gov study NCT00644228. IPD Sharing: Not stated. Countries: 3. Publications: 4.
Combination Therapy Using Lenalidomide (Revlimid)- Low Dose Dexamethasone and Rituximab for Treatment of Rituximab-Resistant, Non-Aggressive B-Cell Lymphomas
ClinicalTrials.gov study NCT00783367. IPD Sharing: Not stated. Countries: 1. Publications: 24.
Pomalidomide, Bortezomib, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT01212952. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Panobinostat or Placebo With Bortezomib and Dexamethasone in Patients With Relapsed Multiple Myeloma
ClinicalTrials.gov study NCT01023308. IPD Sharing: Not stated. Countries: 34. Publications: 4.
Evaluation of Safety of Pomalidomide in Combination With Dexamethasone (Low Dose) in Patients With Refractory or Relapsed and Refractory Multiple Myeloma
ClinicalTrials.gov study NCT01712789. IPD Sharing: Not stated. Countries: 20. Publications: 4.
Intra-Erythrocyte Dexamethasone Sodium Phosphate in Ataxia Telangiectasia Patients
ClinicalTrials.gov study NCT02770807. IPD Sharing: NO. Countries: 12. Publications: 2.
Dexamethasone in Reducing Everolimus-Induced Oral Stomatitis in Patients With Cancer
ClinicalTrials.gov study NCT03839940. IPD Sharing: YES. Countries: 1. Publications: 1.
Phase III Study of Lenalidomide and Dexamethasone With or Without Elotuzumab to Treat Relapsed or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT01239797. IPD Sharing: Not stated. Countries: 23. Publications: 3.
High vs Low Dose Dexamethasone on Complications in the Immediate Postoperative Phase
ClinicalTrials.gov study NCT03161938. IPD Sharing: NO. Countries: 1. Publications: 1.
Post-lesion Administration of Dexamethasone to Prevent the Development of Neuritis After Radiofrequency Ablation
ClinicalTrials.gov study NCT03247413. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Phase II Study of Efficacy and Safety of Lenalidomide, Subcutaneous Bortezomib and Dexamethasone Therapy for Newly Diagnosed Multiple Myeloma
ClinicalTrials.gov study NCT02441686. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Long Term Effectiveness of Trigger Finger Injections With Triamcinolone vs. Dexamethasone
ClinicalTrials.gov study NCT03641508. IPD Sharing: NO. Countries: 1. Publications: 9.
Efficacy of IV Palo With IV Dexamethasone vs IV Palo for Prevention of Immediate & Delayed PONV
ClinicalTrials.gov study NCT00952133. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Study Comparing Daratumumab, Lenalidomide, Bortezomib, and Dexamethasone (D-RVd) Versus Lenalidomide, Bortezomib, and Dexamethasone (RVd) in Subjects With Newly Diagnosed Multiple Myeloma
ClinicalTrials.gov study NCT02874742. IPD Sharing: Not stated. Countries: 1. Publications: 11.
CC-5013 With or Without Dexamethasone in Treating Patients With Primary Systemic Amyloidosis
ClinicalTrials.gov study NCT00091260. IPD Sharing: NO. Countries: 1. Publications: 1.
A Study Comparing Once-weekly vs Twice-weekly Carfilzomib in Combination With Lenalidomide and Dexamethasone in Subjects With Relapsed or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT03859427. IPD Sharing: YES. Countries: 17. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.